Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus with Multiple Cardiovascular Risk Factors. ccm [Internet]. 2023 Apr. 24 [cited 2026 Sep. 17];7(2):141-4. Available from: https://fortunejournals.org/ojs/index.php/ccm/article/view/16403